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Differentiation of Mammary Stem Cells
In Vivo and In Vitro
by Roger Barraclough* and Philip S. Rudland*
The fully differentiated cells ofthe rat mammary parenchyma, the ductal epithelial, alveolar, and myoepi-
thelial cells, are distinguished by their ultrastructure and by their accumulation ofimmunocytochemically
detectable marker proteins. The different cell types probably develop from primative ductal structures called
terminal end buds, which are present in the developing rat mammary glands, and these structures contain
relatively undifferentiated cells.
Clonal epithelial stem cell lines, obtained from normal rat mammary glands orbenign mammary tumors,
differentiate under appropriate conditions alongapathway to droplet-cell/doming cultures ofprimative alveo-
larlike cells. Under different culture conditions, the epithelial stem cells differentiate along a separate path-
way to myoepitheliallike cells. They accumulate some ofthe specific marker proteins ofmyoepithelial cells
in vivo, including type IV collagen, laminin, and Thy-1 antigen. In addition, these myoepitheliallike cells
in culture contain an abundance of a potential calcium-binding protein, p9Ka, which also occurs in myo-
epithelial cells ofhistological sections from mammary glands.
The accumulation oftype IV collagen, laminin, Thy-1, and p9Ka occurs asynchronously along the path-
way to the myoepitheliallike cells in vitro. Furthermore, the steady-state levels ofthese different markerpro-
teins arise by alterations in the controls at the transcriptional, the posttranscriptional processing, and the
translational stages oftheirproduction. These results suggest a stepwise control ofsynthesis ofmyoepithelial
cell markerproteins, and inthe case ofp9Ka andThy-i antigen, this altered control may arise through their
possession of novel transcriptional promoters.
Differentiation of the Mammary
Gland and Its Tumors In Vivo
The mammarygland ofthe adult female rat consists of
a system of branching ducts terminating in alveoli and
embedded in afatty stroma (1). The mammary ducts are
composed of one or more layers of cuboidal, epithelial
cells, some of which border a lumen that is continuous
throughout the ductal system. The epithelial cells are sur-
roundedby alayer ofelongated, myoepithelial cells (2,3).
These two fully differentiated cell types have been distin-
guished in the pastby their characteristic ultrastructural
morphologies. The ductal epithelial cells possess apical
microvilli and specializedjunctional complexes with asso-
ciated desmosomes, whereas the myoepithelial cells pos-
sess smooth musclelike myofilaments with pinocytotic
vesicles and basement membrane on their basal surfaces.
Athirdfunctionally differentiated celltype, the secretory
cell, is found in the mammary alveoli. This cell type is
characterized by its ultrastructure and, duringlactation,
by the synthesis and secretion of milk products (4,5).
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More recently, immunocytochemical stains have been
used to distinguish the ductal epithelial, myoepithelial,
and alveolarcell types. The epithelial cells are stained, for
example, by antisera to milk fat globule membranes (6)
and keratin monoclonal antibody LE61 (7). The myo-
epithelial cells are normally stainedby antisera to vimen-
tin, actin, myosin(6,8), keratin monoclonal antibody LP34
(7,9), and by the lectins Griffonia simplicifolia-1 (GS-1)
and pokeweed mitogen (10). The basement membrane,
which is closelyassociatedwithandpossiblysynthesized
atleast in partby the myoepithelial cells, stains with an-
tisera to laminin, type IV collagen, and Thy-1 antigen
(6,8,11,12). The secretory cells are characterizedbybeing
stained with peanut lectin (13) and, duringlactation, with
antisera to casein (14).
In the rat, the development of the mammary paren-
chyma takes place predominantly after birth but before
puberty(15) by the lengthening and branching ofprima-
tive ducts within the mammary fat pad. During this
period ofgrowth, the ducts terminate in globular struc-
tures called terminal end buds (TEBs), which contain
most ofthe dividingparenchymal cells (16). The number
ofTEBsreaches amaximum in ratsabout20 daysold(16),
andthereafter the numberrapidly declines as the TEBs
differentiate toterninal ducts andalveolarbuds(17). The
alveolar buds are the direct precursors of the secretory
alveoli. The TEBs consist of a heterogeneous collectionBARRACLOUGH AND RUDLAND
ofcells that show agradation inultrastructural andimmu-
nocytochemical-staining characteristics toward the
epithelial cells within the cortex of the TEB on the one
hand, andtothe myoepithelial cells ofthe subtending duct
on the other hand (18,19). Although it isprobable that all
the alveolar cells may arise from differentiation events
within the TEBs and alveolarbuds, itis not entirely clear
whether all the myoepithelial cells arise in this way.
Myoepithelial cells are absentfromthe developingducts
of the mammary glands of young rodents until about 7
days after birth (6,20). Dissection of part of the rodent
mammary gland and transplantation to other suitable
sites in syngeneic animals results in the generation of
fully developed mammary glands at the sites ofimplan-
tation. These implantedglands will secrete milkproducts
in isologous, pregnant hosts (21,22), suggesting arevers-
ible state between ductal and alveolar cells. Bud-free
ducts dissected from rat mammary glands can regener-
ate the entire mammaryparenchyma includingthe TEBs
(23) and casein-producing alveoli in appropriate hosts (24).
These facts raise the possibility that fully differentiated
myoepithelial cells may also arise from cells present
within the bud-free ducts.
The susceptibility ofthe ratmammarygland to chemi-
cal carcinogenesis correlates with the presence in the
gland of TEBs and terminal ducts (25). The tumors in-
duced by dimethylbenzanthracene (DMBA) (26) or
nitrosomethyl urea (NMU) (27) are predominantly cyto-
logically benign in the authors' experience (28). These
relatively benign tumors contain areas of epithelial and
elongated, myoepitheliallike cells in ductlike arrange-
ments (29). However, many of the elongated, myo-
epitheliallike cells possess a more undifferentiated ap-
pearance thanthemyoepithelial cells ofmaturemammary
ducts (30). Hormonal stimulation ofthe hostleads to pro-
duction ofa smallproportion ofalveolarlike cells that can
synthesize casein (31). However, the amount ofcasein and
casein mRNA produced by these cells is only 1 to 5% of
that producedby the alveolar cells ofthe lactating mam-
mary glands in normal rats, when animals bearing the
tumors are subsequently mated (14,31,32).
Morphological Differentiation of
Cultured Normal and Tumorous
Mammary Stem Cells
Limited digestion ofcarcinogen-induced benign mam-
mary tumors, or normal mammary glands, yields orga-
noids that will subsequently adhere tothe surface ofatis-
sue culture vessel, providing that their basement
membrane has notbeen destroyed. The stromal cells ad-
here to the substratum after about2hr, andthe epithelial
fraction adhers after 12to24hr(33,34). Afterseveral days
in culture, epithelial cells grow from the organoids and
single epithelial cells canbe cloned(35). Such single-cell-
cloned epithelial cell lines have been obtained from the
normal mammary glands of 7-day-old inbred, Furth-
Wistar rats (36), from DMBA-induced tumors ofoutbred
Sprague-Dawley rats (35) or inbred, Furth-Wistar rats
(37), andfrom an NMU-inducedratmammarytumor(38).
All the cell lines derived from the normal mammary
glands or benign tumors behave in a similar way. Thus,
the workonthe benigntumor-derived epithelial cell line
Rama 25 is described in detail.
Sequential Changes Associated
with Differentiation to Alveolarlike
Cells In Vitro
Rama25 cellsgrowoncollagengels andform branched,
ductlike structures with a correctly organizedbasement
membrane (39). Such structures arereminiscentofthe im-
mature ducts found in neonatal rat mammary glands.
That the Rama 25 cell line can form such ductlike struc-
tures suggests that it may represent a mammary stem
cell. However, Rama 25 cells are more conveniently cul-
tured on a plastic substratum on which they grow with
a cuboidal, epithelial morphology. When such cultures,
growinginthe presence ofhydrocortisone and insulin, be-
come densely packed, small, dark, polygonal cells are
formed (35) that contain vacuoles or droplets at their
peripheries (droplet cells). These cells form hemispheri-
cal blisters or domes that are thought to arise from the
unidirectional pumpingaction ofthe ouabain-sensitive so-
dium/potassium ATPase (40).
Thepathway ofmorphological differentiation invitroto
the droplet/doming cultures takesplace through alinear
sequence ofmorphological stages in the order cuboidal,
grey, dark, dark-droplet, and domingcells(41). The overall
process can be accelerated by the addition of the
erythroleukemic cell-differentiation inducer, dimethyl sul-
foxide (35,42), or by retinoic acid (43) in the presence of
the mammotrophic hormones prolactin, estrogen, hydro-
cortisone, and insulin. The doming cultures can synthe-
size rat casein as detectedbyradioimmunoassay andthis
casein has apeptide map identical to that ofratP-casein
(44). However, the amount ofcaseinproducedby Rama25
cells is 50- to 100-fold less than that synthesized by lac-
tatingratmammaryglands orculturedexplants(44). This
lowlevel ofcaseinproductionbythedomingRarna25cells
may reflect the fact that the Rama25 cell line was origi-
nally derived from a mammary tumor.
The discrete morphological stages in the formation of
the casein-secreting domingcultures invitro are charac-
terizedbyparallel changes in a small number ofspecific
polypeptides (45); however, the identity and occurrence in
vivo ofmany ofthese stage-specificpolypeptides has not
yet been determined. Droplet, doming cultures ofRama
25 cells also can bind peanut lectin, but only after they
have beentreatedwithneuraminidase. Inthisrespectthe
cultures resemble cells ofthe alveolarbuds ofthe devel-
oping mammary gland, which also require prior neu-
raminidase treatment before peanutlectinwill bind. The
better developed alveolarcells, however, canbindpeanut
lectin extensively withouttheirprior treatment with neu-
raminidase (13). This result suggests that Rama 25 cells
probably resemble cells ofthe early developmental stages
inthe ratmammarygland, andthis mayfurther account
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for the lackofexpression ofthefully differentiatedpheno-
type, for example, the abundant synthesis of casein.
Changes Associated with
Differentiation to Myoepitheliallike
Cells In Vitro
Although Rama 25 cells have been single-cell cloned
three times, confluent cultures at high passage number
yield ridges ofelongated cells (46), and subconfluent cul-
tures yield 1 to 3% of clones of cells with an elongated
morphology (35). The formation ofsimilarmorphological
forms occurs also in cultures ofmouse mammary tumors
(47-49) and in cultures of normal rat mammary glands
(36). From a comparison of the ultrastructure and im-
munocytochemical staining characteristics ofhistological
sections ofrat mammary glands (39,46) and of their pri-
mary cultures (50), the elongated cells derived from cul-
tures of cell line Rama 25 are thought to be related to
myoepithelial cells.
In primary cultures, myoepithelial cells stain with an-
tiserato vimentin (50), Thy-i (24), lami'nin, type IV colla-
gen (50,51), and the lectins GS-1 and pokeweed mitogen
(10), similar to the staining ofmyoepithelial cells andbase-
ment membranes invivo. However, there are some differ-
ences; thus, antisera to actin andmyosin stain only some
ofthe elongated, myoepitheliallike cells inprimary culture
(50). In a similar fashion to theprimary culture:s, the elon-
gated, myoepitheliallike converts from the cloned mam-
mary epithelial cell lines always express vimentin, lami-
nin, type IV collagen, Thy-i (12,46,52-55), andreceptors
for the lectins GS-1 and pokeweed mitogen (10). But, as
with primary cultures, some elongated cell clones stain
well with actin and myosin; others (e.g., Rama 29 cells)
stainpoorly (56). Ingeneral, cells of a more mature myo-
epithelial phenotype have been derived from the
epithelial cells ofnormal rat mammaryglands, for exam-
ple, cell lines Rama 704E (36) and Rama 401 (54), than
from the epithelial cells of mammary tumors, for exam-
ple, Rama29(35) and Rama 37E5(37). This result is con-
sistent with the finding that the better differentiated
myoepithelial cells occur in normal mammary glands
rather than in their tumors. Moreover, subcloning ofthe
better-differentiated myoepitheliallike cell lines in vitro
can also lead to a further loss ofthe microfi'lamental sys-
tems and to a less differentiated cellularphenotype (57).
Thus, based on these results, the majority of the more
elongated cells in vitro are classified asmyoepitheliallike
rather than as mature myoepithelial cells (58).
Polypeptide Changes Associated
with the Differentiation to
Myoepitheliallike Cells In Vitro
The conversion in culture ofthe cuboidal, epithelial cells
to elongated myoepitheliallike cells is accompanied by
changes in a small number of specific polypeptides. Es-
sentially the same changes are also found for the conver-
sion ofepithelial cells derived fromnormalglands orfrom
benign tumors to the elongated myoepitheliallike cells
(55). The pattern of acidic polypeptides from the elon-
gated, myoepitheliallike cell line, Rama29, and that from
the parental cuboidal, epithelial cell line, Rama 25, are
shown in Fig-ure 1. Thepatterns are very similar, only 6%
of the total number of polypeptides resolved show any
quantitative or qualitative changes (59) and ofthese only
nine polypeptides show major changes. Three polypep-
tides show a marked decrease in the elongated cells,
whereas six are more abundant. Polypeptides 3-9 are
components ofthe intermediate filaments within the cells
(59). The same differences are found irrespective of
whether the proteins are located by staining or by radi-
oactive labeling. However, both systems detect only the
most abundantproteins in a cell; the otherproteinaceous
markers of the myoepitheliallike cells, Thy-i, laminin,
TIype IV collagen, the receptors for GS-i and pokeweed
mitogen, are ofmuch lower abundance and are therefore
not readily detected using this technique. However, a
novelpolypeptide ofmolecularweight 9000(Number 1 in
Fig. 1), termedp9Ka, ispresent in abundance in the myo-
epitheliallike cells but is barely detectable in the paren-
tal, cuboidal epithelial cells.
The increase in synthesis of p9Ka by the elongated,
myoepitheliallike cells reflects the presence in these cells
of an increased level of translatable p9Ka mRNA when
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FIGURE 1. The pattern ofpolypeptides of cuboidal epithelial and elon-
gated, myoepitheliallike cell lines following two-dimensional gel elec-
trophoresis. Extracts ofcuboidal epithelial cells, Rama 25(left panel)
or elongated, myoepitheliallike cells, Rama 29 (right panel) radioac-
tively labeledovernight with[35S]methionine, were subjected to iso-
electric focusing in the fi'rst dimension, and SDSgel electrophoresis
in the second dimension. The autoradiographs ofthe dried-downgels
are shown. The large numbers superimposed on thegels refer to poly-
peptides that showmajorquantitative orqualitative variation between
the two cell lines. Polypeptides 7, 8, and 9 show a marked decrease
in the elongated cells relative to the cuboidal cells; polypeptides 1-6
are more abundant in the enlongated cells than in the cuboidal cells.
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compared with the parent cuboidal epithelial cells. The
protein p9Ka has been purified 63-fold from the elongated,
myoepitheliallike cells using a combination of acid extrac-
tion and high-performance liquid chromatography. The
resulting preparation ofp9Ka shows only a trace of con-
taminating polypeptides on SDS polyacrylamide gels, and
appears homogeneous on two-dimensional polyacrylamide
gels when they are stained by Coomassie blue. Although
p9Ka is not a particularly antigenic protein, a mouse an-
tiserum has been raised to the relatively small amounts
ofpurified preparations ofp9Ka that have been available
so far. This mouse antiserum binds to myoepithelial cells
and smooth muscle in histological sections of rat mam-
mary glands (60).
10 20 30 40 50 60 70 80 90
GGATCCAGATGAGAGATTCTGGTACGGAGGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTATTGCACAAGA
100 110 120 130 140 150 160 170 180
ATGAAAACTGAAAAACAAGCAGTATATAAATGGCTCCCGGAGATTCTGAGATGCTGAGGCTTGCTTGTATGTTGCTATAGTGTATGTTGG
190 200 210 220 230 240 250 260 270
TGCTTGGGAGCCACTGTCATGGATAGGTATGTTGCTGGGTCATCCAAGCCAGTGTGTGGACACTCAGGTACAGGAAGCAAAGTGAAGGCA
280 290 300 310 320 330 340 350 360
TCAGCAGGCATTTTTGTTTTACGATGTTTAAATTACACTTATTTTATTTGTGTGTACGAGTGTATGGGTGGGGATGGGGCAAATGCCAAG
370 380 390 400 410 420 430 440 450
GGGCACTTCTTGTGAGAGTCAATCTGTTCCTTCTAGCATGTGGGCTCTGGAGATCAAACTCAGGTCATTGAGCTTGGTGGCAAGCACCTC
460 470 480 490 500 510 520 530 540
TACCTACTGAGCCACCTGTTCAACACCCACCTGTAGGCATTTGTGTTCATAGTAGTTCATAGCCCTATGAACATATAGCACCTAGGCCAA
550 560 570 580 590 600 610 620 630
GAGAGCCTGGCTTCCCCACCCCCTCCCCTTGTACCCCAACCTCTGCCACTTCATCTCACTCCTACTAGGCAGCTGGGTTTTTTCCCTCAC
640 650 660 670 680 690 700 710 720
TGTAGGCCCCTGGGCAGGCAGCCAGCAGCCGCGCCCAACGCTGGGAGGGAGAAGAATGGGTCAGAGGCTGGAGCTTGTGGTTGAGTTGGG
730 740 750 760 770 780 790 800 810
GAGTGAGTAAGCTGAGTGAGGGATGGAAAACTGCTGTTGTTGAGGCCAGGCCTGGGGGGGAGGCACAGAAGGCTGCTGGCATGAATTTCT
820 830 840 850 860 870 880 890 900
AGAGTTTGAGTGGTAAGTTTTGCAAGTTTCAGAGCTTGAAGCACATATGAGCTTCTTGCCATCAGTGGGTACCACTCCTCTGATCTCCCT
910 920 930 940 950 960 970 980 990
A Polypeptide Marker for
Myoepitheliallike Cells is Related to
a Class of Calcium-Binding Proteins
A cloned cDNA corresponding to p9Ka mRNA has
been obtained from a cDNA library constructed with
mRNA from the elongated, myoepitheliallike cell line,
Rama 29 (61). It is complementary to 400 bases at the 3'
end ofthe p9Ka mRNA. This cloned cDNA has been used
to screen a genomic library containing fragments of rat
liver DNA. An 18-kilobase fragment ofrat genomic DNA
that contains the p9Ka gene and its flanking regions has
been isolated from the recombinant library (62). The se-
quence of2340 nucleotides of this gene region has been
determined (Fig. 2), and apotential amino acid sequence
for p9Ka has been deduced from the nucleotide sequence
data. A polypeptide corresponding to a linear sequence
of 12 amino acids from this deduced sequence was synthe-
sized, chemically coupled to keyhole limpet hemocyanin,
and injected into rabbits. The resulting antiserum cross-
reacts with denatured p9Ka separated from other cellu-
lar proteins by two-dimensional gel electrophoresis
(63,64). It also shows the same staining pattern on sec-
tions of rat mammary glands as the antiserum raised
against the purified preparations ofp9Ka (60).
The p9Ka gene sequence (Fig. 2) contains at least one
intervening sequence, orintron, with boundaries that can
be located precisely, because the intervening sequence is
flanked by DNA corresponding to the cloned cDNA to
p9Ka mRNA (Fig. 2). The 5' and 3'boundaries ofthis in-
tron conform to concensus intron/exon boundary se-
quences (65). Apoly(A) addition signal, AATAAA, is pres-
ent atbases numbered 2176 to 2181, and the mRNA ends
at base number 2194. Six separate start sites for the
mRNA have been located to a small region ofthe DNA
between bases numbered 834 and 884. The size of the
p9KamRNA is thus 629 to 680 nucleotides and is consis-
tent with the actual size of700 to 780 nucleotides includ-
ingthe poly(A)tail, when measuredfollowing agarosegel
electrophoresis (61). When the same nucleotide sequence
is translated in all three possible reading frames, it con-
tains only one open reading frame ofsufficient length to
encode apolypeptide of9000 molecular weight. This read-
ingframe contains apotential codingregion of 100 amino
1000 1010 1020 1030 1040 1050 1060 1070 1080
1090 1100 1110 1120 1130 1140
TCACCATG GCG AGA CCC TTG GAG GAG GCC CTG GAT GTA 07A GTG TCC ACC TTC CAC AAA TAC TCA GGC
Met Ala Arg Pro Leu Gl Glu Ala Leu Asp Val Ile Val Ser Thr Phe His Lys Tyr Ser Gly
1160 1170 1180 1190 1200 1210
AAC GAG GGT GAC 88G TTC AAG CTG AAC AAG ACA GAG CTC AAG GAG CTA CTG ACC AGG GAG CTG CCT AGC
Asn Glu Gly Asp Lys Phe Cys Ceu sn Lys Thr '10 Leu 0y0s C Tu Ceu Leu TF1 Org T h eu Pr-o 50er
1230 1240 1250 1260 1270 1280 1290 1300
TTC CTG GGG gtgagtggatcctgtctgtgtattgcatatgtgatgcatccccaggaggaggctggggctggagatatctatctatct Phe LeOu Uy
1310 1320 1330 1340 1350 1360 1370 1380 1390
atctatctatctatctatctatctatctatctatctatctatctatctatctatatctatatcatctatctatatctatctatctatcta
1400 1410 1420 1430 1440 1450 1460 1470 1480
catatatatatatatatatatatatatatatatatatatatatatatatatctctccctactcctggcgcttggtatggaaccacaatga
1490 1500 1510 1520 1530 1540 1550 1560 1570
accatctacttcacaccagccccccgttgagacaaggcttagaatgaagttaactgaagtggcacaagaaaaccacattaggtagtcagt
1580 1590 1600 1610 1620 1630 1640 1650 1660
gtctgaaagcacagcctagatcaggacagtctttccggtgatgtgcaacagaaatcgagtttctgcttgtgaagacatgattgtggaggc
1670 1680 1690 1700 1710 1720 1730 1740 1750
acacaaatgcctgcagatcttccccctcaatgacaccttatcttagttaacacctccCttgtcatgacagttacctatagacatagttaaaa
1760 1770 1780 1790 1800 1810 1820 1830 1840
caagcgtggggaagatgtggtcacatcctttcccagctagcccatgtgCtcatctcacagttgagccctgaggctagcacggtgtctgca
1850 1860 1870 1880 1890 1900 1910 1920
agccttcctgagctcctggctggaggtggcgtctaactgtacctcttCtacctccag AGA AGG ACA GAC GAA GCT GCA TTC
Org 17 Asp 0h 0 F Th FaTh e
1930 1940 1950 1960 1970 1980 1990
CAG AAG CTG ATG AAC AAC TTG GAC AGC AAC AGG GAC AAT GAA GTT GAC TTC CAG GAG TAC TGT GTC TTC
Gln Lys Leu Met As Asn Leu Asp SerAsn Org Asp Vsn 0Tu a TO- 8Fe Siin 0Tu Tyr Cys 'al 8Fe
2000 2010 2020 2030 2040 2050 2060
CTG TCC TGC ATT GCC ATG ATG TGC AAT 00 I TTT GAG GGC TGC CCA GAT AAG GAG CCC CGG AAG AAG
Leau NJ Cys TOe Oa 9e0t 9e1 Cys Asn T 800 Pe00 000 07 Cys Pro Asp Lys 0Tu PrArgo Lys Lys
2070 2080 2090 2100 2110 2120 2130 2140
TGA AGA CTC CTC AGA TGAAGTGTTGGGCCAGTGGGGGAATCTTCCATGTTGGCTGTGAGCATAGTGCCTTACTCTGGCTTCTTCA
2160 2170 2180 2190 2200 2210 2220 2230
TACATGTGCACAGTGCTGAGCAAGTTTMTAAAGAGTTTTGAAACTatgtctgagagactggagattgtgggtgggtgggtgggctgagg
2250 2260 2270 2280 2290 2300 2310 2320
gagggtggtggcagagatggctggaagttgacctggagctttgtggggccaactagaaaaggttggggaggggtgagtgactatctgagt
2340
catacagtgtat
FIGURE 2. The nucleotide sequence ofthe p9Ka gene. The sequence of
the strand of DNA corresponding to the mRNA of p9Ka is shown.
The single intron is shown in lower case letters fromnucleotide num-
bered 1227 to nucleotide numbered 1901. The potential p9Ka coding
region is shown with the corresponding amino acid residues beneath.
The sequence corresponding to the p9Ka cDNA is underlined. The
line above the sequence indicates the single EcoRl site.
acids, excluding the initiating methionine residue and
ends with two termination codons.
The potential amino acid sequence forp9Kais shownin
Figure 3. A search ofcomputerized databases ofprotein
and nucleic acid sequences shows limited homology (66)
ofthis potential p9Ka amino acid sequence to both the a
(43%) and P (43%) chains ofbovine S-100 protein (67,68)
and to rat S-100 protein(42%)(69). This homology is also
observed inthe corresponding nucleic acid sequences. A
cloned cDNA corresponding to aportion ofrat S-100 pro-
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Ala-Arg-Pro-Leu-Glu-Glu-Ala-Leu-Asp-Val-Ile-Val-Ser-Thr-Phe-His-Lys-Tyr-
Lys-Ser-Pro- Glu-Glu- Leu-Lys-Gly-Ile-
HELIX
Phe-Glu-Lys-Tyr-
HELIX
19
Ser-Gly-Asn-Glu-Gly-Asp-Lys-Phe-Lys-Leu-Asn-Lys-Thr-Glu-Leu-Lys-Glu-Leu-Leu-Thr-Arg-Glu-
I * G £ 5* 5* 1 * * G
Ala-Ala-Lys-Glu-Gly-Asp-Pro-Asn-Gln-Leu-Ser-Lys-Glu-Glu-Leu-Lys-Leu-Leu-Leu-Gln-Thr-Glu-
LOOP HELIX
41
p9Ka Leu-Pro-Ser-Phe-Leu-Gly-Arg-Arg-Thr-Asp-Glu-Ala-Ala-Phe-Gln-Lys-Leu-Met-Asn-Asn-Leu-
* * * *
Bov. Phe-Pro-Ser-Leu-Leu- Lys- Gly- Pro-Ser-Thr-Leu-Asp-Glu-Leu-Phe-Glu-Glu-Leu-
CaBP.
LINKER HELIX
62
Asp-Ser-Asn-Arg-Asp-Asn-Glu-Val-Asp-Phe-Gln-Glu-Tyr-Cys-Val-Phe-Leu-Ser-Cys-Ile-Ala-Met-Met-
*5 *5 §* G * *5 *5 *
Asp-Lys-Asn-Gly-Asp-Gly-Glu-Val-Ser-Phe-Glu-Glu-Phe-Gln-Val- Leu- Val-
LOOP
85
p9Ka Cys-Asn-Glu-Phe-Phe-Glu-Gly-Cy-Pro-Asp-Lys-Glu-Pro-Arg-Lys-Lys
Bov.
CaBP.
Lys- Lys-Ile-Ser-Gln
FIGURE 3. The potential amino acid sequence ofp9Ka and its relationship to S-100 protein and bovine intestinal calcium-binding protein. Amino acids
are shown using the three letter code and are arranged according to the maximum homology using the algorithm of Dayhoff(66). Amino acids
in the sequence ofS-100 protein and ofbovine intestinal calcium-binding protein are shown in bold type. The stars between the sequences show
preferred side chains for the EF-hand structure as indicated by Szebenyi et al. (72). Asterisk (*) indicates an amino acid with a hydrophobic side
chain; double asterisks (**) indicate an amino acid with an oxygen-containing side chain; (G) indicatesglycine. The helix, loop, helix arrangements
of the calcium-binding sites are indicated by underscoring.
tein mRNA(69) has an overall homology of66% with the
corresponding region of the p9Ka gene.
The protein p9Ka also shows a weak homology (34%)
with the bovine vitamin D-dependent, intestinal calcium-
binding protein (Fig. 3) (70). This protein has two poten-
tial calcium-binding sites, one of which conforms to the
EF-hand structure of known calcium-binding proteins
(71,72). When only those amino acid residues thought to
be involved in calcium bindingbythe two sites ofbovine
intestinal protein (72) are compared with those in similar
positions inp9Ka, 11 out of 14 ofthese residues are iden-
tical in the two polypeptides. The protein p9Ka also con-
tains two potential calcium-binding loops between
residues 33and40 andresidues 62 and 73(Fig. 3). The C-
terminal loop (residues 62-73) ofp9Ka corresponds to an
almostperfect EF-hand sequence, with five residues con-
taining carboxylic acid derivatives in their side chains
(aspartate 62, asparagine 64, aspartate 66, aspartate 70,
glutamate 73 ofthe p9Ka amino acid sequence) in the ex-
actpositions ofthe loopregion that are thought to be im-
portant in calcium binding by the vitamin D-dependent,
intestinal calcium-binding protein (72,73). In p9Ka this
potential binding site contains asparagine at position 67
instead ofthe smallerglycine residue. This latterresidue
is thought to play a role in maintaining the EF-hand
structure in both S-100 protein and intestinal calcium-
bindingprotein (74). However, this particular substitution
may notprevent calciumbindingbyp9Ka, since the other,
N-terminal loop ofthe intestinal calcium-bindingprotein
also binds calcium, but does not contain this particular
glycine residue (72).
It is not yet known whether one or both of the poten-
tial calcium-binding sites in p9Kabind calcium under ex-
perimental or physiological conditions, or whether, as in
the case of the S-100 protein, calcium binding is modu-
latedbythe presence ofother cations, such aspotassium
and magnesium (75). The relative positions of the two
potential binding sites in p9Ka are similar to those in a
number ofother smallputative calcium-bindingproteins
(Fig. 4). The gene sequences corresponding to these pro-
teins are not yet available. However, in the case of the
gene for p9Ka the single intron interupts the hypotheti-
cal codingregion in the linker between the two potential
calcium-binding sites, thus separating the two functional
domains (62).
In contrast, the genes of proteins with four calcium-
binding sites, such as those of calmodulin (76) and Spec
1 protein (77), contain multiple introns that often inter-
rupt the calcium-binding domains (Figs 4 and5). Whether
all the small calcium-binding proteins have the same in-
tron/exon arrangement is not known. It is interesting to
speculate that the cytoskeletal rearrangement on differ-
entiation of Rama 25 stem cells to the elongated myo-
epitheliallike cells (53) may be triggered, in part, by
calcium-binding proteins acting directly on actin/myosin
polymerization, or indirectly on tubulin polymerization,
since artificial agents that disrupt microtubules trigger
this change (78).
p9Ka
Bov.
CaBP.
P9Ka
Bov.
CaBP.
p9Ka
Bov.
CaBP.
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FIGURE 4. The location ofpotential calcium-binding regions in calcium-binding proteins. The positions of the helix (H), loop (L), helix (H) arrange-
ment alongthe amino acid chains ofsome calcium-bindingproteins are shown as heavylines between the circles. The diagram hasbeen constructed
from the amino acid sequences ofp9Ka, Barraclough et al. (62); S-100 protein (S 100), Isobe and Okuyama (68); bovine intestinal calcium-binding
protein (B. I. Ca. B. P.), FullmerandWasserman (70); p11, Gerke andWeber(88); 2A9, Calabretta et al. (89); parvalbumin (PARV), Kretsinger(90);
troponin C (TROP), Kretsinger (90); and calmodulin (CALM), Simmen et al. (76). The arrows denote the positions ofintrons in the corresponding
gene sequences ofp9Ka and calmodulin. Numbers are the number of residues from the N-terminus.
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FIGURE 5. The transcription and processing of the rat p9Ka gene.
Changes Associated with
Differentiation to Myoepitheliallike
Cells In Vitro are Controlled at
Different Levels of Genetic
Expression
p9Ka, in addition to laminin, type IV collagen, and
Thy-1, is apotential marker ofmyoepithelial cells in vitro
and in vivo. In the elongated cell line Rama29, Thy-1 an-
tigen, Type IV collagen, laminin, and p9Ka are respec-
tively 13-fold, 3.5-fold, 3.7-fold, and 16-fold more abundant
than in the parental cuboidal, epithelial cells (12,56,79).
Cloned cell lines intermediate inmorphology between the
cuboidal and elongated cells have been isolated and these
form a series in the order Rama 25, Rama 25-12, Rama
25-Il, Rama 25-I4, Rama 29, based on increasing elon-
gated character, and, except for Rama 29, increasingfre-
quency ofconversion to the fullyelongated cells(56). This
same order is maintained for increases in myoepithelial
characteristics and decreases in epithelial characteristics,
includingthe markerproteins oftherespective cell types.
However, the individual changes do not occurto the same
degree in the same intermediate cell line. Thus, the
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majority ofthe increase in p9Ka occurs inthe Rama25-Il
cell line, whereas Thy-1 antigen increases predominantly
in Rama 25-Il and I4, and laminin increases almost
equally in Rama 25-I2, I1, and I4 cells. Our results show
that the production ofthese proteins is not synchronous,
and therefore the regulation of their production is ex-
ecuted in an asynchronous manner as well.
This idea ofasynchronous orstepwise regulation ofthe
production of marker proteins for the myoepitheliallike
cell is strengthened by a comparison ofthe relative levels
ofthe mRNAs ofthe same markerproteins in the cuboi-
dal, epithelial and elongated, myoepitheliallike cells. The
levels of mRNA have been estimated by hybridizing
poly(A)-containing RNA from the different cell lines to
radioactive, cloned cDNAs corresponding to themRNAs
forThy-1, p9Ka(61), laminin, andtype IV collagen (Thble
1). Thus, the 16-fold increase in the amount ofThy-1 in the
elongated, myoepitheliallike cells can be completely ac-
counted forby an equivalent increase in Thy-1 mRNA, as
measured by hybridization to Thy-1 cDNA (80). In con-
trast, the 16-fold increase in p9Ka accumulation in the
elongated, myoepitheliallike cells (55) is accompanied by
only a 10-fold increase in p9Ka cytoplasmic mRNA (61).
These results suggest that translational control may play
a facilitating role in the increase in p9Ka. On the other
hand, the 3.7-fold increase in laminin (56) and the 3.5-fold
increase in type IV collagen (79) are accompanied by only
a very small increase in their respective mRNAs (Table
1). The increase in type IVcollagen seeninelongated, my-
oepitheliallike cells relative to the cuboidal, epithelial cells
arisespredominantly from a5-fold decrease inthe rate of
intracellular breakdown of type IV collagen, estimated
from the rate ofrelease ofhydroxyproline (79). The com-
bination of these results strongly suggests that in the
same cells, the steady-state levels ofdifferent marker pro-
teins can arise by altering control at different molecular
levels, including that at transcriptional, posttranscrip-
tional processing orposttranslational steps. It has notyet
been possible to determine whether the altered levels of
Thy-1 mRNA arise from altered control at the initiation
oftranscription or atprocessing oftheThy-1 mRNA tran-
scripts. These two levels of control can be distinguished
bymeasuringthe rate ofcompletion ofnascent RNA tran-
scripts by isolated cell nuclei. However, in our experi-
ments so far, Thy-1 RNA transcripts can be detected at
only very low levels in nuclei from the elongated, myo-
epitheliallike cells and from the cuboidal epithelial cells.
Underthe same conditions, RNAtranscripts correspond-
ingto two other cellularmRNAs arereadilydetected(80).
Thus, it ispossible thatputative factors necessary for the
transcription ofThy-1 mRNA are lost duringisolation of
the nuclei from the elongated, cultured cells, but, at pres-
ent, their identity is completely unknown.
Inthe case ofp9Ka, preliminary evidence suggests that
atleastpartofthe increase in its accumulation inthe myo-
epitheliallike cells in vitro arises from an increased rate
oftranscription ofitsmRNAwhencompared to the cuboi-
dal epithelial cells (unpublished observation). In many
genes, regions ofDNA important in controlling the syn-
thesis oftheirmRNAmolecules are oftenlocated immedi-
ately adjacent to those sequences corresponding to the
5'end ofthemRNA. These regions, such as the TATA(81)
and CAAT (82) concensus sequences are thought to be im-
portant in specifyingthe start site oftranscription ofthe
gene by RNA polymerase. However, no obvious TATA or
CAAT promoter sequences are found close to the region
corresponding to p9Ka mRNA. Genes that do not possess
promoters that contain TATA or CAAT concensus se-
quences in either the coding or the noncoding strand of
DNAhave beenidentified recently(83-87). In atleast two
of these cases, the murine Thy-1,2 gene (85,87) and the
3-hydroxy-3-methylglutaryl coenzyme A reductase gene
(84) multiple initiation sites for the transcription of the
mRNAs have been reported, similar to those found for
the mRNA for p9Ka. The absence of TATA and CAAT
promoter sequences is a characteristic of certain house-
keeping genes (84) that possess promoter regions rich in
GC nucleotide pairs, and short sequences, GGGCGG,
homologous to part ofthe 21 nucleotide-pair repeat ofthe
promoters for SV40 specificmRNAs (84,86). However, al-
though the 5' sequence flanking the gene for p9Ka does
contain some G-rich regions, the above elements are ab-
sent. Thus, it is possible thatthe gene forp9Ka may con-
tain a novel promoter that regulates its expression be-
Table 1. Relative levels of specific marker proteins and their mRNAs rat mammary cell lines.
Relative level of mRNAa
Cuboidal, Elongated,
epithelial myoepitheliallike
Marker protein cell line (Rama 25) cell line (Rama 29) Reference
Thy-1 antigen
Protein ratio 1 16.7 (12)
mRNA ratio 3 experiments 1 16.0 + 2.1 (80)
p9Ka
Protein ratio 1 16.3 (55)
mRNA ratio 4 experiments 1 10.3 + 3.3
Laminin
Protein ratio 1 3.7 (56)
mRNA ratio 2 experiments 1 1.45 + 0.2 (80)
aPoly(A)-containing RNAfrom cell lines was bound to nitrocellulose filters and the relative levels ofspecific mRNAs were found by quantitative
hybridization to 32P-labeled cloned cDNAs.
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tween epithelial andmyoepitheliallike cells. Similarly, the
Thy-1 gene, which is also expressed in myoepitheliallike
cells, but not inepithelial cells, alsolacks CAATandTATA
concensus sequences and contains only a single region
with stronghomology to the GGGCGG sequence (85). A
study ofthe functional promoters ofthe genes for these
two proteins mayleadto anunderstanding ofsome ofthe
molecular control mechanisms of myoepithelial cell
differentiation in vitro and in vivo.
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